trial · primary record
zelicapavir
RSV
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 860 |
| Primary completion | 2029-07 |
| Primary endpoint | Time to complete resolution of all 13 RSV symptoms as assessed by the Respiratory Infection Intensity and Impact Questionnaire (RiiQ) symptom scale |
| Registry ID | NCT07908381 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:30.249Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908381
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.